- Home
- CAC vs ORIC Comparison
CAC vs ORIC Comparison
Compare CAC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- ORIC
- Stock Information
- Founded
- CAC 1875
- ORIC 2014
- Country
- CAC United States
- ORIC United States
- Employees
- CAC N/A
- ORIC N/A
- Industry
- CAC Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- ORIC Health Care
- Exchange
- CAC Nasdaq
- ORIC Nasdaq
- Market Cap
- CAC 616.5M
- ORIC 633.7M
- IPO Year
- CAC 1997
- ORIC 2020
- Fundamental
- Price
- CAC $44.05
- ORIC $9.58
- Analyst Decision
- CAC Hold
- ORIC Strong Buy
- Analyst Count
- CAC 3
- ORIC 9
- Target Price
- CAC $46.67
- ORIC $18.75
- AVG Volume (30 Days)
- CAC 81.6K
- ORIC 597.6K
- Earning Date
- CAC 01-28-2025
- ORIC 03-10-2025
- Dividend Yield
- CAC 3.81%
- ORIC N/A
- EPS Growth
- CAC N/A
- ORIC N/A
- EPS
- CAC 3.20
- ORIC N/A
- Revenue
- CAC $168,756,000.00
- ORIC N/A
- Revenue This Year
- CAC N/A
- ORIC N/A
- Revenue Next Year
- CAC $30.91
- ORIC N/A
- P/E Ratio
- CAC $13.76
- ORIC N/A
- Revenue Growth
- CAC N/A
- ORIC N/A
- 52 Week Low
- CAC $28.62
- ORIC $6.33
- 52 Week High
- CAC $50.07
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- CAC 53.88
- ORIC 54.79
- Support Level
- CAC $43.30
- ORIC $7.86
- Resistance Level
- CAC $44.78
- ORIC $11.15
- Average True Range (ATR)
- CAC 1.10
- ORIC 0.72
- MACD
- CAC 0.31
- ORIC 0.23
- Stochastic Oscillator
- CAC 83.45
- ORIC 52.28
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.